New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For DELL;ADNC;MRK;TSN;CTRP;GDOT;VVUS;NFLX;MCK;MAT;LTM;ALKS;ELN From The Last 14 Days
Check below for free stories on DELL;ADNC;MRK;TSN;CTRP;GDOT;VVUS;NFLX;MCK;MAT;LTM;ALKS;ELN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>
April 24, 2014
12:25 EDTNFLXApple shares cheap, Netflix expensive, Barron's reports
While Apple (AAPL) and Netflix (NFLX) both reported better than expected profit this week, Apple's shares look cheap based on strong cash generation. Netflix, on the other hand, had strong growth, but only generated a small cash profit, and therefore looks pricey, according to Barron's. Reference Link
10:36 EDTNFLXOptions with decreasing implied volatility: SRPT CREE ANGI FIO NFLX
Subscribe for More Information
10:26 EDTNFLXAlbert Fried believes a Netflix and Tivo merger makes sense
Subscribe for More Information
10:10 EDTNFLXNetflix falls for a second session, levels to watch
Subscribe for More Information
09:45 EDTNFLXActive equity options trading on open
Subscribe for More Information
08:14 EDTLTMLife Time Fitness sees FY14 EPS $3.05-$3.15, consensus $3.09
Subscribe for More Information
08:13 EDTLTMLife Time Fitness reports Q1 EPS 69c, consensus 68c
Subscribe for More Information
April 23, 2014
16:57 EDTNFLXOn The Fly: Closing Wrap
Subscribe for More Information
15:55 EDTNFLXNew FCC proposal to let ISPs charge for special access, WSJ says
The Federal Communications Commission plans to propose new "net neutrality" rules on Thursday that would block Internet service providers from discriminating against specific websites, but would allow providers to charge content companies for preferential treatment of their traffic, according to The Wall Street Journal, citing a person familiar with the proposal. Netflix (NFLX) CEO Reed Hastings had been outspoken in the past in his opposition of the FCC's previous net neutrality rules. Broadband ISPs include Comcast (CMCSA), Time Warner Cable (TWC), Cablevision (CVC), Verizon (VZ), and AT&T (T). Reference Link
15:37 EDTNFLXFCC to propose to let ISPs charge content companies for special access, DJ says
Subscribe for More Information
13:42 EDTMATSony, Mattel announce partnership for live-action Barbie film
Sony Pictures Entertainment (SNE) and Mattel (MAT) announced a partnership on a live-action comedy featuring Mattel's Barbie character. The studio said the live-action comedy is set to begin production by the end of the year.
13:35 EDTNFLXNetflix slides after Amazon.com signs content deal with HBO
The shares are down 4.5% to $356 after news earlier today that Amazon.com (AMZN) had signed a content deal with HBO, inlcuding some exclusives. At current price next support is at $350.24. Resistance is at $362.49.
12:51 EDTNFLXOn The Fly: Midday Wrap
Subscribe for More Information
12:36 EDTNFLXNetflix slides after Amazon signs content deal with HBO
Subscribe for More Information
12:09 EDTNFLXAmazon deal with HBO helps Prime catch up with Netflix, says Cantor
Subscribe for More Information
10:40 EDTNFLXOptions with decreasing implied volatility: SRPT CREE NFLX IRBT SVU
Subscribe for More Information
09:48 EDTNFLXNetflix drops 3% after HBO, Amazon enter content agreement
Subscribe for More Information
09:34 EDTNFLXActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL GILD NFLX TSLA VZ MU WFM AMGN
06:54 EDTMRKCambridge Healthtech Institute to hold a conference
Subscribe for More Information
06:54 EDTMRKGlobal Technology Community to hold a summit
7th Annual Diabetes Summit is being held in Cambridge, MA on April 23-25.
06:16 EDTMRKPharmaceutical companies narrowing focus, WSJ reports
Subscribe for More Information
April 22, 2014
17:43 EDTNFLXNetflix expanding to France by year-end, Bloomberg says
Subscribe for More Information
16:33 EDTNFLXOn The Fly: Closing Wrap
Subscribe for More Information
12:39 EDTMRK, NFLXOn The Fly: Midday Wrap
Stocks on Wall Street were higher at midday amid a number of big deals and a much talked about proposed deal in the pharmaceutical industry, as well as another wave of earnings reports. The market opened quietly but on the positive side of the ledger as investors pored over the multitude of quarterly reports issued after the close last night and earlier today. Near noon the market stood near its session highs and is pointing toward its sixth consecutive positive close. ECONOMIC EVENTS: In the U.S., existing home sales slipped 0.2% to a 4.59M rate in March, versus expectation for them to have fallen 1% to a 4.56M rate. The Richmond Fed manufacturing survey for April had a reading of 7, beating the consensus forecast for a reading of 2. COMPANY NEWS: Valeant Pharmaceuticals (VRX) teamed with Bill Ackman's hedge fund Pershing Square to make a hostile takeover offer for Allergan (AGN), sending shares of both companies higher. Allergan confirmed it received the offer of $48.30 in cash and 0.83 shares of Valeant stock for each of its own shares, which it said it will evaluate with the help of its advisers. Analysts' opinion on the fallout varied, with one firm suggesting Allergan could pursue its own takeover of Shire (SHPG) or Jazz Pharmaceuticals (JAZZ) as a defense, and another saying a rival big pharma company, such as Johnson & Johnson (JNJ) or Merck (MRK), could launch a competing bid for Allergan. Shares of Allergan led all gainers on the S&P 500, rising 16%, while Valeant shares gained more than 6%... A number of other big drug makers made news with a string of deals, as Novartis (NVS) and GlaxoSmithKline (GSK) both reshaped their companies via a trio of agreements. Novartis will acquire GSK's oncology products for a $14.5B payment and up to $1.5B contingent future payments, Novartis will sells its Vaccines business, excluding flu, to GSK for $7.1B plus royalties, and the two agreed to tie-up their consumer healthcare businesses through a joint venture. In a separate transaction, Novartis agreed to divest its Animal Health Division to Eli Lilly (LLY) for about $5.4B. MAJOR MOVERS: Among the notable gainers following their earnings reports were streaming video service Netflix (NFLX), which advanced almost 6%, and motorcycle maker Harley-Davidson (HOG), which rose 8%. Companies that slid following their earnings reports included printer maker Lexmark (LXK), which fell over 11%, and Pentair (PNR), which dropped almost 6%. INDEXES: Near midday, the Dow was up 106.77, or 0.65%, to 16,556.02, the Nasdaq was up 45.95, or 1.11%, to 4,167.50, and the S&P 500 was up 11.59, or 0.62%, to 1,883.48.
12:37 EDTNFLXNetflix rises after earnings beat, sooner than expected price hike
Subscribe for More Information
11:22 EDTMRKAnalysts think Valeant bid for Allergan could spur higher offer, rival deal
After Valeant Pharmaceuticals (VRX) teamed with hedge fund Pershing Square to make a hostile takeover offer for Allergan (AGN), analysts' opinion on the fallout varied, with one firm suggesting Allergan could pursue its own takeover as a defense and another believing Valeant will be pushed to raise its offer. WHAT'S NEW: Valeant, in partnership with Bill Ackman's Pershing Square, offered to combine with Allergan for $48.30 in cash and 0.83 shares of Valeant stock for each share of Allergan. Allergan has confirmed it received the offer and said that it would evaluate the proposal. ANALYST OPINION: In a note to investors, Wells Fargo stated that it believes that Valeant's low tax rate will enable it to raise its bid. Moreover, one or more big pharmaceutical companies, such as Johnson & Johnson (JNJ) or Merck (MRK), could launch a competing bid for Allergan, added Wells. The firm believes that Allergan could ultimately be purchased for $165 per share. Research firm Jefferies said it expects Allergan's board to oppose Valeant's takeover attempt. The firm suggested that Allergan could seek to fend off Valeant's takeover attempt by acquiring Shire (SHPG) or Jazz Pharmaceuticals (JAZZ). Jefferies kept a Hold rating on Allergan. BMO Capital similarly believes that Valeant will have to overcome significant hurdles in order to complete the deal. The management teams of the two companies have different views and Allergan's business could be damaged by significant cost cutting following the deal, according to the firm. Nonetheless, it kept an Outperform rating on the Botox maker. PRICE ACTION: In mid-morning trading, Allergan rallied 15.5% to $164, Valeant gained 4.4% to $133, Jazz shares rose 6.4% to $147.18 and Shire added 4.8% to $158.62.
10:42 EDTNFLX Options with decreasing implied volatility: SRPT NFLX YOKU UVXY
Subscribe for More Information
10:00 EDTNFLXOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:38 EDTNFLXActive equity options trading on open
Subscribe for More Information
09:16 EDTNFLXOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Netflix (NFLX), up 8%... Harley-Davidson (HOG), up 7%... PLX Technology (PLXT), up 8%... Illinois Tool (ITW), up 2.3%... Comcast (CMCSA), up 1%... McDonald's (MCD), up 0.6%. ALSO HIGHER: Allergan (AGN), up 17% after Valeant (VRX) confirms proposal to combine with the company for $48.30 and 0.83 shares of stock. Valeant is up 5% following its confirmation of the news that broke last night... GlaxoSmithKline (GSK), up 4.5% after agreeing to sell oncology products for $14.5B to Novartis (NVS) and buy Novartis' Vaccines business, currently excluding its flu business, for $7.1B plus royalties. Novartis shares trading in New York are also up 1% following the deals... Revance Therapeutics (RVNC), up 20% after announcing positive results from RT002 Phase 1/2 study... Facebook (FB), up 2% following upgrade at Credit Suisse. DOWN AFTER EARNINGS: Xerox (XRX), down 4%... Lexmark (LXK), down 4.8%. ALSO LOWER: Allison Transmission (ALSN), down 4% after filing to sell 25M shares for holders... FireEye (FEYE), down 2.9% after filing to sell 13.3M shares of common stock for holders... Bebe stores (BEBE), down 16% after reporting preliminary Q3 losses that were steeper than the consensus estimate.
08:14 EDTNFLXNetflix price target raised to $520 from $500 at Pacific Crest
Subscribe for More Information
07:50 EDTNFLXNetflix price target raised to $435 from $419 at Oppenheimer
Subscribe for More Information
07:34 EDTNFLXNetflix guidance, commentary positive, says Stifel
Subscribe for More Information
07:24 EDTGDOTSourceMedia to hold a forum
26th Annual Card Forum & Expo is being held in Orlando on April 22-25.
07:10 EDTNFLXNetflix blames AT&T for below-average streaming speeds, Bloomberg says
Subscribe for More Information
06:11 EDTMRKWells says big pharma bidders could emerge for Allergan
Wells Fargo believes Allergan (AGN) wants to remain independent and says the "hurdle to convince the company to sell could be pretty high." Wells thinks Valeant's (VRX) low tax rate gives it room to raise its bid for Allergan, and it sees the potential for one or more big pharma bidders, such as Johnson & Johnson (JNJ) or Merck (MRK), emerging due to Allergan's "attractive eye care and aesthetics portfolio and pipeline." Wells believes a purchase price for Allergan of $50B or $165 per share could be justified.
05:59 EDTNFLXNetflix price target raised to $434 from $412 at Piper Jaffray
Subscribe for More Information
05:45 EDTNFLXNetflix upgraded to Outperform from Market Perform at Raymond James
Subscribe for More Information
05:30 EDTNFLXNetflix upgraded to Buy from Hold at Cantor
Cantor Fitzgerald upgraded its rating on Netflix (NFLX) shares to Buy from Hold citing the company's stronger than expected Q1 results and better Q2 guidance. Cantor views the stock as more compelling given Netflix's international expansion and $1-$2 price hike later this quarter. The firm raised its price target for shares to $425 from $405.
April 21, 2014
19:45 EDTNFLXComcast responds to Netflix opposition to Time Warner Cable deal
Subscribe for More Information
19:02 EDTNFLXOn The Fly: After Hours Movers
NOTABLE: Allergan (AGN), up 20%, and Valeant Pharmaceuticals (VRX), up 9.1%, both advanced after The Wall Street Journal reported that activist investor Bill Ackman is teaming up with Valeant to make a bid for Allergan. Following the report, Ackman's Pershing Square filed a 13D with the SEC disclosing a 9.7% stake in Allergan and outlining an agreement with Valeant. The agreement, among other things, said that Valeant plans to make a bid for Allergan comprised of $15B of cash and a to-be-determined amount of Valeant stock. The filing also showed that Ackman began building a position in Allergan in late February, and at that time entered an agreement with Valeant forming a new, jointly-owned entity through which to acquire a position in Allergan. CNBC's David Faber reported that Valeant is expected to officially make a hostile bid for Allergan by tomorrow. UP AFTER EARNINGS: Netflix (NFLX) gained 6.3% after reporting profits that beat expectations on revenues that were in-line with expectations. The streaming internet video service also reported that U.S. subscribers grew by 2.25M in the first quarter, with its international subscriber base expanding by 1.75M for the period. DOWN AFTER EARNINGS: Rambus (RMBS) fell 7.5% after providing a second quarter revenue outlook that fell short of expectations, with the company adding that its revenue outlook, "includes expectations that the company will sign new customers for patent as well as solutions licensing." Rambus' first quarter results, however, came in better than expected, and the company also reaffirmed its fiscal 2014 revenue outlook.
17:31 EDTNFLXNetflix sees reaching 60M-90M U.S. subscribers
17:18 EDTNFLXNetflix says original content competing with 'top end of cable'
Comment made on company's Q1 earnings webcast.
16:24 EDTNFLXNetflix says opposes Comcast-Time Warner Cable deal
"If the Comcast (CMCSA) and Time Warner Cable (TWC) merger is approved, the combined company’s footprint will pass over 60% of U.S. broadband households, after the proposed divestiture, with most of those homes having Comcast as the only option for truly high-speed broadband. As DSL fades in favor of cable Internet, Comcast could control high-speed broadband to the majority of American homes. Comcast is already dominant enough to be able to capture unprecedented fees from transit providers and services such as Netflix (NFLX). The combined company would possess even more anti-competitive leverage to charge arbitrary interconnection tolls for access to their customers. For this reason Netflix opposes this merger," the company said.
16:10 EDTNFLXNetflix shares up 3% after Q1 results
Subscribe for More Information
16:10 EDTNFLXNetflix says opposes Comcast-Time Warner Cable deal
Subscribe for More Information
16:07 EDTNFLXNetflix sees adding $1-$2 per month for new subscribers
Subscribe for More Information
16:06 EDTNFLXNetflix says House of Cards season 2 attracted 'huge' audience
Subscribe for More Information
16:04 EDTNFLXNetflix sees adding 520,000 domestic subscribers in Q2
Sees adding 940,000 international subscribers in Q2. Sees total members 49.81M in Q2, reports 48.35M total members at Q1-end.
16:03 EDTNFLXNetflix Q1 net international subscriber additions 1.75M
16:03 EDTNFLXNetflix Q1 net domestic additions 2.25M
Subscribe for More Information
16:02 EDTNFLXNetflix sees Q2 EPS $1.12, consensus $1.00
16:02 EDTNFLXNetflix reports Q1 EPS 86c, consensus 83c
Subscribe for More Information
16:01 EDTNFLXOptions Update; April 21, 2014
iPath S&P 500 VIX Short-Term Futures down 78c to 40.03. Option volume leaders: AAPL C GILD NFLX TSLA TWTR FB WLT according to Track Data.
15:16 EDTNFLXNotable companies reporting after market close
Subscribe for More Information
13:37 EDTNFLXEarnings Preview: Comcast set for first report after Time Warner Cable deal
Subscribe for More Information
13:18 EDTNFLXNetflix technical commentary ahead of earnings
Subscribe for More Information
13:05 EDTNFLXEarnings Preview: Netflix shares trading up 3% since last earnings report
Subscribe for More Information
12:43 EDTNFLXNetflix April weekly 345 straddle priced for 11.6% move into Q1
10:57 EDTMATOptions with decreasing implied volatility: GOOGL ATHN SNDK SPXU MAT
09:36 EDTNFLXActive equity options trading on open
Subscribe for More Information
09:02 EDTNFLXNetflix April weekly volatility elevated at 126 into Q1 and outlook
Subscribe for More Information
07:21 EDTMRKFDA Pediatric Advisory Committee to hold a meeting
The Committee discusses pediatric-focused safety reviews including MDT's Activa Dystonia Therapy, (BAX's Advate and Tisseel, NVS' Famvir, Tibotec's (JNJ subsidiary) Intelence, UCB Pharma's Keppra, MRK's Maxalt, BAYRY's Natazia, Digestive Care's Pertzye, JNJ's Prezista, BMY's Reyataz, SNY's Sklice, PFE's Torisel, Aptalis' Ultresa, and GILD's Viread in a meeting being held in Bethesda, Maryland on April 21 at 8 am. Webcast Link
April 19, 2014
20:17 EDTNFLXTwitter, Netflix, Amazon look pricey, Barron's says
Subscribe for More Information
11:12 EDTMRKLeerink's pharma and biotech analysts hold an analyst/industry conference call
Subscribe for More Information
April 17, 2014
16:35 EDTALKSAlkermes recent pullback a buying opportunity, says Leerink
Leerink does not expect any surprises when Alkermes reports Q1 results and views the recent pullback in shares as a buying opportunity. The firm reiterates an Outperform rating on the stock with a $66 price target.
16:31 EDTNFLXOn The Fly: Closing Wrap
Subscribe for More Information
14:55 EDTNFLXNetflix rallies after upgrade, Vodafone content deal talks
Subscribe for More Information
13:50 EDTMRKFDA approves Ragwitek for short ragweed pollen allergies
Subscribe for More Information
12:59 EDTMATMattel falls after reporting lower Q1 international, North American sales
Subscribe for More Information
12:46 EDTNFLXVodafone, Netflix in talks on content deal, Bloomberg says
Vodafone (VOD) is in early stage talks with Netflix (NFLX) to offer Vodafone customers free access access to its streaming service for a period of time, according to Bloomberg, citing three people familiar with the talks. Reference Link
10:17 EDTNFLXStocks with call strike movement; FB NFLX
Subscribe for More Information
09:59 EDTNFLXOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:35 EDTNFLXActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL GOOGL GOOG NFLX TSLA AMZN GOLG NOV AA IBM
09:01 EDTMATMattel sees FY14 CapEx $230M-$240M
Subscribe for More Information
08:58 EDTMATOn The Fly: Pre-market movers
Subscribe for More Information
08:38 EDTMATMattel maintains FY14 gross margin view within low-to-mid 50% range
Subscribe for More Information
06:58 EDTNFLXNetflix, Comcast deal questioned by senator, NY Post says
Subscribe for More Information
06:18 EDTMATMattel CEO: global retail environment in Q1 "challenging"
Subscribe for More Information
06:17 EDTMATMattel reports Q1 international sales down 7%
Q1 international sales inlcude a 1% unfavorable impact from changes in currency exchange rates.
06:16 EDTMATMattel reports Q1 North American sales down 2%
Subscribe for More Information
06:04 EDTMATMattel reports Q1 EPS (3c), consensus 9c
Subscribe for More Information
05:33 EDTNFLXNetflix upgraded to Outperform from Sector Perform at Pacific Crest
Pacific Crest upgraded its rating on Netflix (NFLX) to Outperform from Sector Perform on expectations the company's international growth will accelerate meaningfully over the next 18 months. The firm has a $500 price target for shares.
April 16, 2014
16:00 EDTNFLXOptions Update; April 16, 2014
Subscribe for More Information
15:17 EDTMATNotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's market open, with earnings consensus, include General Electric (GE), consensus 32c; Philip Morris (PM), consensus $1.16; Schlumberger (SLB), consensus $1.20; PepsiCo (PEP), consensus 75c; Union Pacific (UNP), consensus $2.37; UnitedHealth (UNH), consensus $1.09; Honeywell (HON), consensus $1.26; Goldman Sachs (GS), consensus $3.44; du Pont (DD), consensus $1.59; Morgan Stanley (MS), consensus 60c; Danaher (DHR), consensus 80c; BlackRock (BLK), consensus $4.14; Blackstone (BX), consensus 55c; Chipotle Mexican Grill (CMG), consensus $2.86; Mattel (MAT), consensus 9c; Snap-on (SNA), consensus $1.54; AutoNation (AN), consensus 74c.
13:00 EDTNFLXNetflix to launch Germany service in September, GigaOM says
Subscribe for More Information
12:16 EDTTSNPost likely to beat out Tyson for Michael Foods, WSJ says
Subscribe for More Information
12:08 EDTNFLXStocks with call strike movement; TWTR NFLX
Subscribe for More Information
10:16 EDTNFLXNetflix April weekly volatility elevated at 106 into Q1 and outlook
Subscribe for More Information
09:36 EDTNFLXActive equity options trading on open
Subscribe for More Information
07:53 EDTNFLXNetflix Q1 results should be solid, says RW Baird
Baird expects Netflix to report solid Q1 results and remains bullish on the company's medium and long-term opportunities. The firm, however, does not expect to see meaningful upside to subscriber growth due to seasonality. Baird keeps an Outperform rating and $470 price target on the stock.
06:27 EDTNFLXNBCUniversal planning digital video push
Subscribe for More Information
April 15, 2014
13:14 EDTNFLXNetflix volatility elevated up as shares pullback to six-month low into Q1
Subscribe for More Information
10:55 EDTCTRPCtrip.com price target raised to $53 from $39 at Piper Jaffray
Subscribe for More Information
08:23 EDTMRKLeerink's pharma and biotech analysts hold an analyst/industry conference call
Subscribe for More Information
08:19 EDTMRKLeerink's pharma and biotech analysts hold an analyst/industry conference call
Subscribe for More Information
08:10 EDTMATMattel April volatility elevated at 60 into Q1 and outlook
Subscribe for More Information
06:32 EDTMRKPatients paying much more for specialty drugs, NY Times says
The amount that patients with certain diseases must pay for specialty drugs has increased significantly, a research firm reported, according to The New York Times. Meanwhile, consumers' use of health care increased in 2013 for the firm time in three years, the newspaper quoted the firm, the IMS Institute for Healthcare Informatics, as saying. Publicly traded drug makers include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). Publicly traded health insurers include AMERIGROUP (AGP), Aetna (AET), Centene (CNC), Cigna (CI), Health Net (HNT), Healthspring (HS), Humana (HUM), Molina Healthcare (MOH), UnitedHealth (UNH), WellCare (WCG) and WellPoint (WLP).Reference Link
April 14, 2014
18:00 EDTMRKU.S. FDA approves Merck's GRASTEK
Subscribe for More Information
13:19 EDTNFLXNetflix's streaming speeds on Comcast jumped, The Verge reports
Subscribe for More Information
09:36 EDTNFLXActive equity options trading on open
Subscribe for More Information
06:08 EDTMRKMerck volatility elevated into Q1 and outlook
Subscribe for More Information
April 11, 2014
15:44 EDTTSNTyson, Post final contenders to buy Michael Foods, Reuters says
Michael Foods, the egg and dairy products maker that has been put up for sale by Goldman Sachs' (GS) private equity arm, is evaluating binding bids from Tyson (TSN) and Post (POST) and is near a deal to be sold to one of the two for close to $2.5B, according to Reuters, citing people familiar with the matter. Reference Link
10:56 EDTCTRPOptions with increasing implied volatility: CYTK VJET DATA GRPN CTRP
10:29 EDTCTRPRumor: Ctrip.com moves up on renewed takeover chatter
Subscribe for More Information
09:37 EDTNFLXActive equity options trading on open
Subscribe for More Information
07:06 EDTVVUSVIVUS announces avanafil clinical data presentation
Subscribe for More Information
05:22 EDTMRKMerck says Hepatitis C combination therapy shows antiviral activity
Subscribe for More Information
April 10, 2014
17:44 EDTMRKMerck stock could return 20%, Barron's says
Subscribe for More Information
16:00 EDTNFLXOptions Update; April 10, 2014
Subscribe for More Information
12:52 EDTNFLXCarl Icahn says eBay separation 'not if but when'
Subscribe for More Information
10:00 EDTNFLX, ALKSOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:37 EDTMRKActive equity options trading on open
Active equity options trading on open according to Track Data: SIRI RAD AAPL AMZN AA FB TSLA MRK CVX C
09:21 EDTMRKOn The Fly: Pre-market Movers
Subscribe for More Information
08:44 EDTNFLXNetflix upgraded to Buy from Hold at Hudson Square
Subscribe for More Information
08:03 EDTMRKXencor Merck receives milestone payment from Merck for using XmAb antibody
Xencor (XNCR) announced that the company has received a milestone payment from Merck (MRK), through a subsidiary, triggered by the initiation of a Phase 1 clinical trial for an undisclosed biologic drug candidate that uses Xencor's XmAb antibody engineering intellectual property. Under the terms of the agreement signed in June 2013, Xencor granted Merck a non-exclusive license to certain Xencor patents for use in an undisclosed product, as well as an option to license the same intellectual property for future products. Xencor received an upfront payment and continues to receive annual maintenance fees. Xencor is also eligible to receive milestone payments associated with the successful development of Merck product candidates, as well as royalties on sales of any potential products that may result from this agreement.
05:55 EDTALKSAlkermes upgraded to Buy from Neutral at Mizuho
Subscribe for More Information
05:27 EDTMRKMerck announces data from C-WORTHy study
Merck announced additional data from the ongoing C-WORTHy study, a multi-arm Phase 2 clinical trial evaluating the efficacy and safety of a once-daily, all-oral regimen combining MK-5172, an investigational hepatitis C virus, or HCV, NS3/4A protease inhibitor, and MK-8742, an investigational HCV NS5A replication complex inhibitor, among patients with chronic HCV Genotype 1 infection, or GT1. In an interim analysis of treatment-naïve, non-cirrhotic patients administered a 12-week regimen of MK-5172/MK-8742, with and without ribavirin, or RBV, a sustained viral response, or SVR, was observed in 98% of patients administered MK-5172/MK-8742 alone and 94% in those administered MK-5172/MK-8742 plus RBV.
<< 1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use